Patent · US Active

Trientine prodrugs, pharmaceutical compositions thereof, and methods of use

US9738620B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 7, 2015
Grant dateAug 22, 2017
Priority date
Expiry dateNov 20, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Trientine prodrugs, pharmaceutical compositions comprising the trientine prodrugs, and methods of using trientine prodrugs and pharmaceutical compositions thereof for treating Wilson's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.